Old Web
English
Sign In
Acemap
>
Paper
>
P1.03-026 Interim Results of a Phase I Study of Nivolumab plus Nab-Paclitaxel/Carboplatin in Patients with NSCLC
P1.03-026 Interim Results of a Phase I Study of Nivolumab plus Nab-Paclitaxel/Carboplatin in Patients with NSCLC
2017
Jonathan W. Goldman
David Waterhouse
Ben George
P. J. O'Dwyer
Tianlei Chen
Nataliya Trunova
Karen Kelly
Keywords:
Nab-paclitaxel
Carboplatin
Nivolumab
Pathology
Interim
Oncology
Internal medicine
Medicine
in patient
phase i study
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]